All Sir Patrick Vallance articles
-
News
Pharma's UK dissatisfaction mounts as Merck & Co axes $1.3bn expansion
Biotech and research investments from Lilly and AstraZeneca also put on hold as pricing row rumbles on.
Biotech and research investments from Lilly and AstraZeneca also put on hold as pricing row rumbles on.